Evidence map›Paper›PMID 41315310›Full record

ArticleNature communications2025

In-situ cross-linking mass spectrometry reveals compartment-specific proteasomal interactions and structural heterogeneity.

Lili Zhao, Runtao Zhao, Zhou Gong, Fuxiang Liang, Nan Zhao, Bowen Zhong, Maili Liu, Yukui Zhang, Qun Zhao, Lihua Zhang and 1 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lili Zhao *State Key Laboratory of Medical Proteomics, National Chromatographic R. & A. Center, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, China.ORCID http://orcid.org/0000-0003-2175-9246
Runtao Zhao *Beijing National Laboratory for Molecular Sciences, College of Chemistry and Molecular Engineering, Peking University, Beijing, China.ORCID http://orcid.org/0009-0001-2945-2225
Zhou Gong *State Key Laboratory of Magnetic Resonance Spectroscopy and Imaging, Innovation Academy for Precision Measurement Science and Technology, Chinese Academy of Sciences, Wuhan, Hubei, 430071, China.
Fuxiang LiangDepartment of Thoracic Surgery, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.ORCID http://orcid.org/0000-0003-3420-6763
Nan ZhaoState Key Laboratory of Medical Proteomics, National Chromatographic R. & A. Center, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, China.
Bowen ZhongState Key Laboratory of Medical Proteomics, National Chromatographic R. & A. Center, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, China.
Maili LiuState Key Laboratory of Magnetic Resonance Spectroscopy and Imaging, Innovation Academy for Precision Measurement Science and Technology, Chinese Academy of Sciences, Wuhan, Hubei, 430071, China.ORCID http://orcid.org/0000-0002-9359-915X
Yukui ZhangState Key Laboratory of Medical Proteomics, National Chromatographic R. & A. Center, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, China.
Qun ZhaoState Key Laboratory of Medical Proteomics, National Chromatographic R. & A. Center, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, China. zhaoqun@dicp.ac.cn.
Lihua ZhangState Key Laboratory of Medical Proteomics, National Chromatographic R. & A. Center, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, China. lihuazhang@dicp.ac.cn.ORCID http://orcid.org/0000-0003-3798-2047
Chun TangBeijing National Laboratory for Molecular Sciences, College of Chemistry and Molecular Engineering, Peking University, Beijing, China. tang_chun@pku.edu.cn.ORCID http://orcid.org/0000-0001-6477-6500

Funding

Dalian Institute of Chemical Physics (Dalian Institute of Chemical Physics of Chinese Academy of Sciences) XDB0540302Ministry of Science and Technology of the People's Republic of China (Chinese Ministry of Science and Technology) 2023YFF1204400National Natural Science Foundation of China (National Science Foundation of China) 22161132013National Natural Science Foundation of China (National Science Foundation of China) 22322411National Natural Science Foundation of China (National Science Foundation of China) 92353304
6 · The paper itself

Abstract

The proteasome is an essential cellular machine that degrades ubiquitinated substrate proteins to maintain proteostasis. Studies of purified proteasomes, however, cannot fully recapitulate its complexity. Here, we employ in-situ cross-linking mass spectrometry (XL-MS) combined with nuclear-cytoplasmic fractionation to characterize human 26S proteasome within intact cells. Our analysis reveals extensive compositional and conformational heterogeneity between subcellular compartments, along with distinct interactomes and dynamic states. Notably, we identify additional ubiquitin-associated proteasomal subunits and uncover compartment-specific ubiquitin-binding and ubiquitination patterns. Further we identify previously unreported proteasome-interacting proteins, including deubiquitinase USP15, and reveal a hybrid proteasome variant wherein translation initiation factor EIF3M substitutes for subunit Rpn9. Leveraging cross-linking-derived distance restraints, we model transient interactions and dynamic subcomplexes of the proteasome. Together, our work establishes a robust framework for in-situ structural analysis of large protein complexes and provides mechanistic insights into how compartment-specific architectures and interactions regulate proteasome function.

Indexed as

Mass SpectrometryProteasome Endopeptidase ComplexCross-Linking ReagentsEukaryotic Initiation Factor-3HEK293 CellsHeLa CellsHumansProtein BindingUbiquitinUbiquitinationATP dependent 26S proteaseCross-Linking ReagentsEukaryotic Initiation Factor-3Proteasome Endopeptidase ComplexUbiquitin

Identifiers

PMID41315310
PMCPMC12663562

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.